Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials

Background and aims: Metabolic diseases are globally popular, and a systematic review and meta-analysis of turmeric and curcuminoids on glucose metabolism among people with metabolic diseases was performed. Design: We comprehensively searched Web of Science, PubMed, Ovid (including EMBASE and MEDLIN...

Full description

Bibliographic Details
Main Authors: Fen Yuan, Wenbin Wu, Leyi Ma, Dingkun Wang, Meilin Hu, Jing Gong, Ke Fang, Lijun Xu, Hui Dong, Fuer Lu
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661822000664
_version_ 1797366643237584896
author Fen Yuan
Wenbin Wu
Leyi Ma
Dingkun Wang
Meilin Hu
Jing Gong
Ke Fang
Lijun Xu
Hui Dong
Fuer Lu
author_facet Fen Yuan
Wenbin Wu
Leyi Ma
Dingkun Wang
Meilin Hu
Jing Gong
Ke Fang
Lijun Xu
Hui Dong
Fuer Lu
author_sort Fen Yuan
collection DOAJ
description Background and aims: Metabolic diseases are globally popular, and a systematic review and meta-analysis of turmeric and curcuminoids on glucose metabolism among people with metabolic diseases was performed. Design: We comprehensively searched Web of Science, PubMed, Ovid (including EMBASE and MEDLINE), Scopus, the Cochrane Library and two Chinese databases, Wanfang and CNKI for RCTs that focused on the effects of turmeric and curcuminoids on fasting blood glucose (FBG), hemoglobin A1C (HbA1c), fasting serum insulin (FSI) and HOMA-IR among patients with metabolic diseases. The FBG and HbA1c were the main outcomes to be analyzed. With random-effects models, separate meta-analyses were conducted by inverse-variance and reported as WMD with 95% CIs. Results: Evidence from 17 RCTs including 22 trials showed that turmeric and curcuminoids lowered FBG by − 7.86 mg/dL (95% CI: −12.04, −3.67 mg/dL; P = 0.0002), HbA1c by − 0.38% (95% CI: −0.52%, −0.23%; P < 0.00001) and HOMA-IR by − 1.01 (95% CI: −1.6, −0.42; P = 0.0008). Moreover, they decreased fasting serum insulin by − 1.69 mU/L (95% CI: −3.22, −0.16 mU/L; P = 0.03) after more than 8 weeks of intervention in a subgroup analysis. Conclusions: Turmeric and curcuminiods decrease FBG, HbA1c and HOMA-IR significantly among subjects with metabolic disease. Additionally, they may have an effect on FSI concentrations if the intervention period is more than 8 weeks. However, attention should be paid to these outcomes due to the significant heterogeneity.
first_indexed 2024-03-08T17:06:37Z
format Article
id doaj.art-2b68fb02f38a4bc3a8c5be5e86f0955c
institution Directory Open Access Journal
issn 1096-1186
language English
last_indexed 2024-03-08T17:06:37Z
publishDate 2022-03-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj.art-2b68fb02f38a4bc3a8c5be5e86f0955c2024-01-04T04:36:28ZengElsevierPharmacological Research1096-11862022-03-01177106121Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trialsFen Yuan0Wenbin Wu1Leyi Ma2Dingkun Wang3Meilin Hu4Jing Gong5Ke Fang6Lijun Xu7Hui Dong8Fuer Lu9Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, ChinaInstitution of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, ChinaInstitution of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei 430030, China; Corresponding author.Background and aims: Metabolic diseases are globally popular, and a systematic review and meta-analysis of turmeric and curcuminoids on glucose metabolism among people with metabolic diseases was performed. Design: We comprehensively searched Web of Science, PubMed, Ovid (including EMBASE and MEDLINE), Scopus, the Cochrane Library and two Chinese databases, Wanfang and CNKI for RCTs that focused on the effects of turmeric and curcuminoids on fasting blood glucose (FBG), hemoglobin A1C (HbA1c), fasting serum insulin (FSI) and HOMA-IR among patients with metabolic diseases. The FBG and HbA1c were the main outcomes to be analyzed. With random-effects models, separate meta-analyses were conducted by inverse-variance and reported as WMD with 95% CIs. Results: Evidence from 17 RCTs including 22 trials showed that turmeric and curcuminoids lowered FBG by − 7.86 mg/dL (95% CI: −12.04, −3.67 mg/dL; P = 0.0002), HbA1c by − 0.38% (95% CI: −0.52%, −0.23%; P < 0.00001) and HOMA-IR by − 1.01 (95% CI: −1.6, −0.42; P = 0.0008). Moreover, they decreased fasting serum insulin by − 1.69 mU/L (95% CI: −3.22, −0.16 mU/L; P = 0.03) after more than 8 weeks of intervention in a subgroup analysis. Conclusions: Turmeric and curcuminiods decrease FBG, HbA1c and HOMA-IR significantly among subjects with metabolic disease. Additionally, they may have an effect on FSI concentrations if the intervention period is more than 8 weeks. However, attention should be paid to these outcomes due to the significant heterogeneity.http://www.sciencedirect.com/science/article/pii/S1043661822000664CurcuminiodsGlycometabolismMeta-analysisMetabolic diseasesTurmeric
spellingShingle Fen Yuan
Wenbin Wu
Leyi Ma
Dingkun Wang
Meilin Hu
Jing Gong
Ke Fang
Lijun Xu
Hui Dong
Fuer Lu
Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Pharmacological Research
Curcuminiods
Glycometabolism
Meta-analysis
Metabolic diseases
Turmeric
title Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
title_full Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
title_fullStr Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
title_full_unstemmed Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
title_short Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
title_sort turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases a systematic review and meta analysis of randomized controlled trials
topic Curcuminiods
Glycometabolism
Meta-analysis
Metabolic diseases
Turmeric
url http://www.sciencedirect.com/science/article/pii/S1043661822000664
work_keys_str_mv AT fenyuan turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT wenbinwu turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT leyima turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT dingkunwang turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT meilinhu turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT jinggong turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT kefang turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT lijunxu turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT huidong turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT fuerlu turmericandcurcuminiodsamelioratedisordersofglycometabolismamongsubjectswithmetabolicdiseasesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials